Radient Pharmaceuticals Corporation fka RXPC

[jimtash]

Important patent and trademark info. Filings are current and up to date and still owned by Radient.

This application comes up as still docketed. They applied for it in 2009.

Application Number: 12/414,518 Customer Number: -
Filing or 371 (c) Date: 03-30-2009 Status: Docketed New Case - Ready for Examination
Application Type: Utility Status Date: 02-20-2013
Examiner Name: DENT, ALANA HARRIS Location: What is a Location? ELECTRONIC
Group Art Unit: 1643 Location Date: -
Confirmation Number: 1078 Earliest Publication No: US 2010-0248269 A1
Attorney Docket Number: 1958416-00017 Earliest Publication Date: 09-30-2010
Class / Subclass: 435/007.920 Patent Number: -
First Named Inventor: Andrea Small-Howard , Norwalk, CA (US) Issue Date of Patent: -
Title of Invention: DETECTION OF FIBRIN AND FIBRINOGEN DEGRADATION PRODUCTS AND ASSOCIATED METHODS OF PRODUCTION AND USE FOR THE DETECTION AND MONITORING OF CANCER

http://portal.uspto.gov/pair/PublicPair

Trademark.

DR-70 is still trademarked. It's the logo and word mark that was cancelled and was changed, not the actual test itself. AMDL is the owner of it which as we all know is Radient now.

Word Mark DR-70
Goods and Services IC 005. US 006 018 044 046 051 052. G & S: Reagents for clinical medical laboratory use sold as a component of a diagnostic kit for disease testing. FIRST USE: 19960501. FIRST USE IN COMMERCE: 19970501
Standard Characters Claimed
Mark Drawing Code (4) STANDARD CHARACTER MARK
Trademark Search Facility Classification Code LETS-2 DR Two letters or combinations of multiples of two letters
NOTATION-SYMBOLS Notation Symbols such as Non-Latin characters,punctuation and mathematical signs,zodiac signs,prescription marks
NUM-26-UP 70 Other Numerals - 26 and Up
Serial Number 77664344
Filing Date February 5, 2009
Current Basis 1A
Original Filing Basis 1A
Published for Opposition June 22, 2010
Registration Number 3843610
International Registration Number 1011476
Registration Date September 7, 2010
Owner (REGISTRANT) AMDL, Inc. CORPORATION DELAWARE 2492 Walnut Street Tustin CALIFORNIA 92780
Attorney of Record Louis C. Cullman
Type of Mark TRADEMARK
Register PRINCIPAL
Live/Dead Indicator LIVE

And for Onko Sure.

Word Mark ONKO-SURE
Goods and Services IC 005. US 006 018 044 046 051 052. G & S: In vitro diagnostic test kits consisting primarily of polyclonal antibodies, buffers, and reagents for use in detecting cancer. FIRST USE: 20090401. FIRST USE IN COMMERCE: 20090414
Standard Characters Claimed
Mark Drawing Code (4) STANDARD CHARACTER MARK
Trademark Search Facility Classification Code NOTATION-SYMBOLS Notation Symbols such as Non-Latin characters,punctuation and mathematical signs,zodiac signs,prescription marks
Serial Number 77687179
Filing Date March 10, 2009
Current Basis 1A
Original Filing Basis 1B
Published for Opposition July 21, 2009
Registration Number 3811791
Registration Date June 29, 2010
Owner (REGISTRANT) RADIENT PHARMACEUTICALS CORPORATION CORPORATION DELAWARE 2492 Walnut Avenue, Suite 100 TUSTIN CALIFORNIA 927806953
Assignment Recorded ASSIGNMENT RECORDED
Attorney of Record Robert C. Cumbow
Type of Mark TRADEMARK
Register PRINCIPAL
Live/Dead Indicator LIVE

http://www.uspto.gov/trademarks/